We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+20.91%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$173M
AUM Growth
+$20M
Cap. Flow
-$415K
Cap. Flow %
-0.24%
Top 10 Hldgs %
35.73%
Holding
114
New
14
Increased
30
Reduced
33
Closed
8

Top Buys

Rank Stock Value
1
STRM
Streamline Health Solutions
STRM
+$2.62M
2
DGII icon
Digi International
DGII
+$2.23M
3
CEMI
Chembio diagnostics, Inc.
CEMI
+$1.61M
4
RYM
RYTHM Inc
RYM
+$1.57M
5
ZIXI
Zix Corporation
ZIXI
+$1.51M

Top Sells

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$7.28M
2
VCEL icon
Vericel Corp
VCEL
+$4.43M
3
BEAT
BioTelemetry, Inc.
BEAT
+$2.35M
4
SOLO
Electrameccanica Vehicles Corp. Ltd.
SOLO
+$2.21M
5
INUV icon
Inuvo
INUV
+$2.03M

Sector Composition

Rank Sector Weight
1 Healthcare 63.04%
2 Technology 16.06%
3 Communication Services 5.94%
4 Industrials 4.11%
5 Consumer Staples 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SENS icon
101
Senseonics Holdings Inc
SENS
$270M
$50K 0.03%
950
-2,450
-72% -$139K
SRTS icon
102
Sensus Healthcare
SRTS
$48.4M
$38K 0.02%
10,000
-5,500
-35% -$22.6K
ATHX
103
DELISTED
Athersys, Inc. Common Stock
ATHX
$31K 0.02%
680
+140
+26% +$7.27K
AIRI icon
104
Air Industries Group
AIRI
$13M
$24K 0.01%
1,600
– –
TONX
105
TON Strategy Co
TONX
$159M
$17K 0.01%
2
– –
CXDO icon
106
Crexendo
CXDO
$215M
– –
-55,000
Closed -$381K
HEPA
107
DELISTED
Hepion Pharmaceuticals
HEPA
– –
-150
Closed -$329K
TELA icon
108
TELA Bio
TELA
$41M
– –
-11,000
Closed -$165K
TEVA icon
109
Teva Pharmaceuticals
TEVA
$40.5B
– –
-20,000
Closed -$193K
VMAR icon
110
Vision Marine Technologies
VMAR
$4.34M
– –
0
– -$881K
VVOS icon
111
Vivos Therapeutics
VVOS
$4.73M
– –
-800
Closed -$118K
SOLO
112
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
– –
-357,500
Closed -$2.21M
ZAGG
113
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
– –
-40,000
Closed -$167K
BEAT
114
DELISTED
BioTelemetry, Inc.
BEAT
– –
-32,535
Closed -$2.35M
1 2 3 4
5

Similar funds

PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return
WLG
Williamson Legacy Group Carmel, Indiana $133M AUM 151.36% 1-Year Est. Return
PA
PW Advisors Tallahassee, Florida $133M AUM

Perkins Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Perkins Capital Management held 114 positions worth $173M, up 13% from $153M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Perkins Capital Management's Q1 2021 filing shows 14 new, 30 increased, 33 reduced and 8 closed positions. Its largest new stake was Chembio diagnostics, Inc.: 289,680 shares worth $1.02M. The largest sale was Magnite, an estimated $7.28M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 64% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q1 2021 buy was Chembio diagnostics, Inc.: 289,680 shares worth $1.02M.
  • Perkins Capital Management added most to Streamline Health Solutions in Q1 2021, an estimated $2.62M increase.
  • Perkins Capital Management's biggest Q1 2021 reduction was Magnite, cutting an estimated $7.28M.
  • Perkins Capital Management fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $2.35M.
  • Perkins Capital Management's ten largest holdings make up 36% of its $173M portfolio in Q1 2021.
  • Perkins Capital Management opened 14 new positions and closed 8 in Q1 2021.
  • Perkins Capital Management's portfolio value rose 13% quarter-over-quarter to $173M.

Based on Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.